Income from Continuous Operations: A company's total income or loss before discontinued operations, extraordinary items, preferred stock dividends and accounting change.
Avenue Therapeutics, Inc. (ATXI) had Income from Continuous Operations of $-0.69M for the most recently reported fiscal quarter, ending 2025-09-30.
| Income Statement Financials | |
-- |
|
$-0.68M |
|
-- |
|
-- |
|
$0.72M |
|
$-0.72M |
|
$0.03M |
|
$-0.69M |
|
$-0.69M |
|
$-0.69M |
|
|
Income from Continuous Operations |
$-0.69M |
$-0.69M |
|
$-0.69M |
|
$-0.72M |
|
$-0.72M |
|
3.18M |
|
3.18M |
|
$-0.21 |
|
$-0.21 |
|
| Balance Sheet Financials | |
$3.73M |
|
-- |
|
-- |
|
$3.73M |
|
$1.42M |
|
-- |
|
-- |
|
$1.42M |
|
$2.30M |
|
$2.30M |
|
$2.30M |
|
3.18M |
|
| Cash Flow Statement Financials | |
$-0.98M |
|
-- |
|
$2.09M |
|
$2.59M |
|
$3.71M |
|
$1.11M |
|
$0.52M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.62 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-0.98M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-30.05% |
|
-30.05% |
|
-18.58% |
|
-30.05% |
|
$0.72 |
|
$-0.31 |
|
$-0.31 |
|